Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Cash Flow 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Operating Cash Flow | 3.63B | -492.6M | 3.54B | 4.13B | 2.64B | 3.25B | 1.57B | 1.27B | 844.9M | 236.1M | -365.4M | -573.1M | -60.7M | 267.8M | 143.7M | -635.4M | -427.6M | -226.5M |
| Depreciation & Amort. | 209.8M | 207.2M | 181.3M | 148.3M | 125.6M | 109.5M | 106.9M | 72.4M | 61.4M | 61.4M | 62.3M | 63.3M | 48.4M | 38.2M | 35.0M | 30.5M | 30.1M | 32.2M |
| Investing Activities | ||||||||||||||||||
| Capital Expenditure | 437.6M | 297.7M | 200.4M | 204.7M | 235.0M | 259.8M | 75.4M | 95.4M | 99.4M | 56.6M | 45.3M | 51.2M | 51.4M | 71.1M | 34.6M | 38.1M | 23.5M | 32.2M |
| Free Cash Flow | 3.19B | -790.3M | 3.34B | 3.93B | 2.41B | 2.99B | 1.49B | 1.17B | 745.5M | 179.5M | -410.7M | -624.3M | -112.1M | 196.7M | 109.1M | -673.5M | -451.1M | -258.7M |
| Financing Activities | ||||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 2.02B | 1.18B | 427.6M | 0 | 1.43B | 539.1M | 186.0M | 350.0M | 0 | 0 | — | — | — | — | — | — | — | — |
Vertex Pharmaceuticals Inc. Cash Flow — FAQ
Vertex Pharmaceuticals Inc. (VRTX) cash flow over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's cash flow history?
The chart and table above show Vertex Pharmaceuticals Inc.'s cash flow by year and by quarter, including the growth rate.